The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1360
ISSUE1360
March 21, 2011
Saxagliptin/Metformin (Kombiglyze XR) for Type 2 Diabetes
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Saxagliptin/Metformin (Kombiglyze XR) for Type 2 Diabetes
March 21, 2011 (Issue: 1360)
Metformin (Glucophage, and others) is generally preferred as the first-line agent for treatment of type 2 diabetes, but most patients subsequently require treatment with more than one drug. Many combination products have been marketed; the latest of...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.